- Investing Ideas
- Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
14
Mid-Large Cap Stocks
14 companies
Novartis
Market Cap: CHF 219.1b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 121.00
7D
1.6%
1Y
27.4%
Roche Holding
Market Cap: CHF 258.4b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 327.80
7D
1.2%
1Y
26.5%
Tecan Group
Market Cap: CHF 1.9b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 149.90
7D
-2.4%
1Y
-7.8%
Bachem Holding
Market Cap: CHF 4.9b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 67.10
7D
0.1%
1Y
16.2%
Cosmo
Market Cap: CHF 1.1b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 69.70
7D
-1.1%
1Y
22.1%
Sandoz Group
Market Cap: CHF 29.8b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 68.78
7D
4.2%
1Y
58.5%
SKAN Group
Market Cap: CHF 1.1b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 49.30
7D
-2.2%
1Y
-31.5%
Galderma Group
Market Cap: CHF 40.5b
Operates as a dermatology company worldwide.
GALD
CHF 172.85
7D
3.7%
1Y
56.1%
Kuros Biosciences
Market Cap: CHF 796.7m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 19.60
7D
-3.9%
1Y
-23.7%
Lonza Group
Market Cap: CHF 34.5b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 493.30
7D
-1.1%
1Y
-11.8%
Dottikon ES Holding
Market Cap: CHF 4.1b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries.
DESN
CHF 297.00
7D
3.5%
1Y
2.8%
Idorsia
Market Cap: CHF 1.1b
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 4.65
7D
6.2%
1Y
131.3%
Siegfried Holding
Market Cap: CHF 2.9b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 67.00
7D
-12.8%
1Y
-28.8%
PolyPeptide Group
Market Cap: CHF 1.2b
Operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally.
PPGN
CHF 36.55
7D
8.1%
1Y
72.8%